Cambrex: ‘Either we invest now or turn away API business”
Ongoing demand for large-scale APIs combined with high capacity utilization has driven Cambrex Corporation to allot up to $85m (€70m) for manufacturing expansion in 2015.
Archives for February 9, 2015
Pfizer 'comfortable' with Hospira's manufacturing network after quality review
Pfizer visited three troubled facilities in Hospira’s manufacturing network before entering a $17bn definitive merger agreement, the company says.
GSK to consolidate vaccines R&D ahead of Novartis unit takeover
GSK will close a vaccine R&D lab in Montana and establish a centralised development hub as it prepares to takeover Novartis jabs unit.
Chinese researchers develop nanocarrier for pancreatic cancer drug
Researchers from the Oncology Department of Tianjin Medical University Cancer Hospital in China recently published a study in Advanced Functional Materials announcing the creation of a new nano-carrier for pancreatic cancer treatments.
Dispatches from InformEx
US-EU trade agreement not likely until 2017, SOCMA says
Pharmaceutical and chemical manufacturers may have to wait until 2017 to see the benefits of the Transatlantic Trade and Investment Partnership, VP of SOCMA (Society of Chemical Manufacturers and Affiliates) told attendees at InformEx in New Orleans.
Medidata: Big Pharma drove sales but CRO partnerships rising
CRO partnerships almost doubled last year for cloud-based data firm Medidata, which reported total revenues up 21% on 2013.